BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 19520579)

  • 1. Structure-based shape pharmacophore modeling for the discovery of novel anesthetic compounds.
    Ebalunode JO; Dong X; Ouyang Z; Liang J; Eckenhoff RG; Zheng W
    Bioorg Med Chem; 2009 Jul; 17(14):5133-8. PubMed ID: 19520579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel approach to structure-based pharmacophore search using computational geometry and shape matching techniques.
    Ebalunode JO; Ouyang Z; Liang J; Zheng W
    J Chem Inf Model; 2008 Apr; 48(4):889-901. PubMed ID: 18396858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analogs of methyllycaconitine as novel noncompetitive inhibitors of nicotinic receptors: pharmacological characterization, computational modeling, and pharmacophore development.
    McKay DB; Chang C; González-Cestari TF; McKay SB; El-Hajj RA; Bryant DL; Zhu MX; Swaan PW; Arason KM; Pulipaka AB; Orac CM; Bergmeier SC
    Mol Pharmacol; 2007 May; 71(5):1288-97. PubMed ID: 17308033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for high-affinity volatile anesthetic binding in a natural 4-helix bundle protein.
    Liu R; Loll PJ; Eckenhoff RG
    FASEB J; 2005 Apr; 19(6):567-76. PubMed ID: 15791007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The common chemical motifs within anesthetic binding sites.
    Bertaccini EJ; Trudell JR; Franks NP
    Anesth Analg; 2007 Feb; 104(2):318-24. PubMed ID: 17242087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of anesthetic barbiturates by a protein binding site: a high resolution structural analysis.
    Oakley S; Vedula LS; Bu W; Meng QC; Xi J; Liu R; Eckenhoff RG; Loll PJ
    PLoS One; 2012; 7(2):e32070. PubMed ID: 22359658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual screening and scaffold hopping based on GRID molecular interaction fields.
    Ahlström MM; Ridderström M; Luthman K; Zamora I
    J Chem Inf Model; 2005; 45(5):1313-23. PubMed ID: 16180908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding site and affinity prediction of general anesthetics to protein targets using docking.
    Liu R; Perez-Aguilar JM; Liang D; Saven JG
    Anesth Analg; 2012 May; 114(5):947-55. PubMed ID: 22392968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noble gas binding to human serum albumin using docking simulation: nonimmobilizers and anesthetics bind to different sites.
    Seto T; Isogai H; Ozaki M; Nosaka S
    Anesth Analg; 2008 Oct; 107(4):1223-8. PubMed ID: 18806031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining pharmacophore fingerprints and PLS-discriminant analysis for virtual screening and SAR elucidation.
    Askjaer S; Langgård M
    J Chem Inf Model; 2008 Mar; 48(3):476-88. PubMed ID: 18281962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
    Klabunde T; Giegerich C; Evers A
    J Med Chem; 2009 May; 52(9):2923-32. PubMed ID: 19374402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fuzzy tricentric pharmacophore fingerprints. 2. Application of topological fuzzy pharmacophore triplets in quantitative structure-activity relationships.
    Bonachéra F; Horvath D
    J Chem Inf Model; 2008 Feb; 48(2):409-25. PubMed ID: 18254617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for generating less toxic P-selectin inhibitors: pharmacophore modeling, virtual screening and counter pharmacophore screening to remove toxic hits.
    Ananthula RS; Ravikumar M; Pramod AB; Madala KK; Mahmood SK
    J Mol Graph Model; 2008 Nov; 27(4):546-57. PubMed ID: 18993099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond the virtual screening paradigm: structure-based searching for new lead compounds.
    Schlosser J; Rarey M
    J Chem Inf Model; 2009 Apr; 49(4):800-9. PubMed ID: 19354328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallographic study of inhibitors of tRNA-guanine transglycosylase suggests a new structure-based pharmacophore for virtual screening.
    Brenk R; Meyer EA; Reuter K; Stubbs MT; Garcia GA; Diederich F; Klebe G
    J Mol Biol; 2004 Apr; 338(1):55-75. PubMed ID: 15050823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacophore identification and virtual screening for methionyl-tRNA synthetase inhibitors.
    Bharatham N; Bharatham K; Lee KW
    J Mol Graph Model; 2007 Mar; 25(6):813-23. PubMed ID: 16996282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards more accurate pharmacophore modeling: Multicomplex-based comprehensive pharmacophore map and most-frequent-feature pharmacophore model of CDK2.
    Zou J; Xie HZ; Yang SY; Chen JJ; Ren JX; Wei YQ
    J Mol Graph Model; 2008 Nov; 27(4):430-8. PubMed ID: 18786843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postulated receptors for inhalational anesthetic agents.
    Halsey MJ
    Acta Anaesthesiol Belg; 1979; 30 Suppl():45-50. PubMed ID: 547664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach.
    Nguyen TL; McGrath C; Hermone AR; Burnett JC; Zaharevitz DW; Day BW; Wipf P; Hamel E; Gussio R
    J Med Chem; 2005 Sep; 48(19):6107-16. PubMed ID: 16162011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The site of anesthetic action.
    Urban BW
    Handb Exp Pharmacol; 2008; (182):3-29. PubMed ID: 18175084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.